NCT00389168View on ClinicalTrials.gov

Irbesartan and Atenolol in Hypertensive Heart Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

April 30, 1995

Primary Completion Date

April 30, 1997

Study Completion Date

April 30, 1997

Conditions
Hypertension
Interventions
DRUG

Irbesartan

Titrated to 300 mg od, 48 weeks.

DRUG

Atenolol

Titrated to 100 mg od, 48 weeks.

Trial Locations (1)

SE-182 88

Karolinska Institutet, Daprtment of Clinical Sciences, Danderyd Hospital, Cardiovascular Research Laboratory, Stockholm

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Sanofi

INDUSTRY

collaborator

Swedish Heart Lung Foundation

OTHER

lead

Karolinska Institutet

OTHER